Pharmacology

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
Article Anesthesiology Published 1 Jun 2026
Dose-dependent Effects of Propofol on GABAergic Neurotransmission in the Pre-Bötzinger Complex and Its Consequences on Respiratory Rhythm.
AI-generated abstract summary · verify against the original paper
  • Mouse study combining whole-body plethysmography, optogenetics, conditional VGAT knockout, and patch clamp in acute medullary slices examined propofol effects on pre-BötC respiratory rhythm.
  • Propofol was compared across doses, and optogenetic activation of pre-BötC GABAergic neurons was tested alone and with propofol; GABAergic neurons were also ablated.
  • Propofol produced dose-dependent bidirectional respiratory effects, from mild excitation to marked suppression, with correlated excitatory and inhibitory effects on pre-BötC glutamatergic neurons; no effect sizes are reported in the abstract.
  • Authors conclude propofol has a dose-dependent bidirectional effect on respiratory drive via pre-BötC GABAergic neurons; ablation increased apnea incidence during continuous infusion while aiding recovery after a single bolus.
PubMed indexed 1 Jun 2026 Imported 9 Nov 2026 Jiang J et al. Publisher Pharmacology
RCT Anesth Analg Published 28 May 2026
Dexmedetomidine Preemptive Analgesia on Intra- and Postoperative Pain in Noncardiac Surgery: A Randomized, Double-Blind, Controlled Study.
AI-generated abstract summary · verify against the original paper
  • Single-center, double-blind randomized trial of 220 patients undergoing noncardiac surgery, comparing dexmedetomidine with saline placebo.
  • Dexmedetomidine 1.5 µg/kg/h IV was started 15 minutes before induction and continued until 15 minutes after induction.
  • NOX compliance was 90.7% (98/108) with dexmedetomidine versus 12.5% (14/112) with placebo (P < .001). Postoperative NRS >3 was lower at all time points, e.g., 2.8% vs 25.9% at 0 hours.
  • Dexmedetomidine also reduced rescue opioid consumption and postoperative nausea and vomiting, and the authors report improved hemodynamic stability and a favorable safety profile.
PubMed indexed 28 May 2026 Imported 9 Nov 2026 Wang X et al. Publisher Pharmacology
Meta-analysis Anaesthesia Published 26 May 2026
Prophylactic interventions to prevent rebound pain after peripheral nerve block in adults: a systematic review and network meta-analysis of randomised controlled trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and network meta-analysis of 24 randomised trials including 2,130 adults undergoing surgery with single-injection peripheral nerve blocks.
  • Compared eight pharmacological prophylactic strategies against control for preventing rebound pain after nerve block.
  • Intravenous dexamethasone had the highest probability of reducing rebound pain incidence (SUCRA 0.91) and was judged definitely superior to control.
  • Perineural dexamethasone and dexmedetomidine ranked highest for delaying rebound pain, while certainty of evidence ranged from very low to moderate.
PubMed indexed 26 May 2026 Imported 9 Nov 2026 Singh NP et al. Publisher PharmacologyRegional
RCT Anesthesiology Published 22 May 2026
Opioid-free Anesthesia in Cardiac Surgery: The OFACAR Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, blinded, two-center French superiority trial of 320 adults undergoing elective cardiac surgery with cardiopulmonary bypass.
  • Patients received opioid-free anesthesia with ketamine, dexamethasone, lidocaine and magnesium, or opioid anesthesia with sufentanil.
  • The 30-day composite of complications or death occurred in 75.4% versus 84.5% (RR 0.90; 95% CI 0.80 to 0.99; P = 0.049), with a fragility index of 1.
  • The authors call the results hypothesis generating; cardiovascular and digestive complications and deaths were also lower with opioid-free anesthesia.
PubMed indexed 26 May 2026 Imported 9 Nov 2026 Guinot PG et al. Publisher CardiacPerioperative medicinePharmacology
Review Paediatr Anaesth Published 21 May 2026
Codeine and Metabolite Concentrations in the Breastfed Neonate.
AI-generated abstract summary · verify against the original paper
  • This is a pharmacokinetic compartment model, not a clinical study, so no patient sample size is reported.
  • The model simulates maternal codeine ingestion across CYP2D6 metabolizer genotypes, including ultra-rapid metabolizers, and transfer of morphine into breastmilk.
  • Predicted neonatal morphine concentrations stayed below 1 μg/L regardless of maternal genotype; no confidence intervals or p values are reported.
  • The authors conclude that neonatal opioid toxicity from breastfeeding is implausible and that the current ban on codeine for breastfeeding postpartum women should be reviewed.
PubMed indexed 21 May 2026 Imported 9 Nov 2026 Anderson BJ et al. Publisher PediatricPharmacology
RCT Anesthesiology Published 20 May 2026
Preoperative Olanzapine and Quality of Recovery after Ambulatory Surgery: A Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Single-center, double-blind, placebo-controlled RCT of 384 women aged 18 to 50 undergoing ambulatory surgery under general anesthesia.
  • Participants received oral 5 mg olanzapine or placebo, with both groups also receiving dexamethasone and ondansetron prophylaxis.
  • Olanzapine raised QoR-40 scores on POD 1 by 9.0 points (95% CI, 6.1 to 11.8; P < 0.001).
  • Olanzapine also lowered the odds of any nausea on POD 1 (OR 0.43) and POD 2 (OR 0.48), while PACU length of stay did not differ.
PubMed indexed 20 May 2026 Imported 9 Nov 2026 Guzzi J et al. Publisher PediatricPerioperative medicinePharmacology
Meta-analysis Neurocrit Care Published 18 May 2026
Efficacy of Dexmedetomidine in Preventing Postoperative Delirium in Patients Undergoing Brain Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of five randomized controlled trials, including 646 adults undergoing brain surgery, with searches run through April 2025.
  • Evaluated perioperative dexmedetomidine, given as a loading dose followed by a maintenance infusion, for preventing postoperative delirium.
  • The pooled risk ratio was 0.47 (95% CI 0.35-0.63; p < 0.00001), a 53% reduction in delirium risk, with no heterogeneity (I2 = 0%).
  • Subgroups showed similar effects across brain tumor and other cranial procedures, adverse events were comparable and mostly mild, and the authors call for multicenter trials.
PubMed indexed 18 May 2026 Imported 9 Nov 2026 Dos Reis MAOM et al. Publisher NeuroPerioperative medicinePharmacology
RCT Anesthesiology Published 8 May 2026
Choice of Anesthesia in Microelectrode Recording-guided Deep Brain Stimulation Surgery for Parkinson's Disease (CHAMPION): A Noninferiority Randomized Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • Prospective noninferiority RCT of 188 patients with Parkinson's disease randomized 1:1 to undergo elective bilateral deep brain stimulation surgery.
  • Desflurane general anesthesia, titrated to electrophysiologic signal quality, was compared with dexmedetomidine conscious sedation.
  • High-quality microelectrode recording occurred in 89.4% versus 90.3% (difference -0.96%, 95% CI -9.62 to 7.70), and general anesthesia shortened operative time by 9.07 min (P < 0.001).
  • Six-month UPDRS change, levodopa equivalent dose, and complication rates were comparable between groups, and the authors conclude general anesthesia is noninferior.
PubMed indexed 8 May 2026 Imported 9 Nov 2026 Xie S et al. Publisher Pharmacology
Meta-analysis Anesth Analg Published 8 May 2026
Respiratory Depression after Perioperative Methadone Administration: A Systematic Review and Meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 25 studies including 116,815 surgical patients, with 12 RCTs (n = 845) in the primary analysis.
  • Compared perioperative intravenous methadone with other opioids, with respiratory depression defined as naloxone use, respiratory rate under 8/min, or SpO2 under 90%.
  • Respiratory depression occurred in 7.7% of methadone patients versus 6.6% of controls, RR 1.22 (95% CI 0.76-1.95), which was not significant.
  • The authors found no higher risk with methadone, but rated certainty of evidence as very low, and most data came from retrospective datasets.
PubMed indexed 8 May 2026 Imported 9 Nov 2026 Nunez-Rodriguez E et al. Publisher Perioperative medicinePharmacology
Article Exp Neurol Published 30 Apr 2026
Dexmedetomidine mitigates postoperative delirium in aged mice via TFEB-linked restoration of microglial lysosomal function and attenuated neuroinflammation.
AI-generated abstract summary · verify against the original paper
  • Preclinical study in aged mice using a laparotomy-with-visceral-manipulation model, comparing Sham, POD, and POD+DEX groups with behavioral, hippocampal, and primary microglia analyses.
  • Dexmedetomidine treatment was compared against untreated POD mice, with in vitro work using TFEB knockdown in LPS-stimulated primary microglia.
  • DEX improved POD-like behaviors and reduced microglial activation and pro-inflammatory cytokines, with increased lysosomal protein expression and TFEB nuclear translocation; no effect sizes or p values are reported in the abstract.
  • The authors conclude that TFEB activation may restore microglial lysosomal function and that enhancing lysosomal function could be a potential POD target; DEX also inhibited NLRP3 signaling, which TFEB knockdown substantially attenuated.
PubMed indexed 1 May 2026 Imported 9 Nov 2026 Chen N et al. Publisher NeuroPerioperative medicinePharmacology
Article J Cardiothorac Vasc Anesth Published 29 Apr 2026
Effects of Fixed-Dose Postoperative Dexmedetomidine on Delirium and Early Clinical Outcomes After Cardiovascular Surgery: A Retrospective Cohort Study of 408 Patients.
AI-generated abstract summary · verify against the original paper
  • Single-center retrospective cohort of 408 adults undergoing elective cardiovascular surgery (2022–2023), comparing a fixed postoperative dexmedetomidine infusion (n = 188) with no dexmedetomidine (n = 220).
  • Exposure was a 24-hour infusion at 0.2 μg/kg/h versus no postoperative dexmedetomidine, with delirium assessed by CAM-ICU at 6 and 24 hours.
  • Delirium was less frequent with dexmedetomidine at 6 hours (2.1% vs 7.0%, p = 0.032) and 24 hours (0.5% vs 3.6%, p = 0.042); adjusted OR at 6 hours was 0.25 (95% CI 0.07–0.88).
  • Dexmedetomidine was also linked to shorter extubation time (6.85 ± 1.49 vs 9.47 ± 5.61 hours, p < 0.001) and similar adverse events and mortality, though the authors call for prospective confirmation.
PubMed indexed 21 May 2026 Imported 9 Nov 2026 Yılmaz Ş et al. Publisher CardiacCritical careNeuroPerioperative medicinePharmacology
Article Anesth Analg Published 27 Apr 2026
Perioperative Dexamethasone in Periprosthetic Joint Infection Surgery: Diabetes-Stratified Results From a Propensity Score-Matched Retrospective Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Retrospective, propensity-matched analysis of 61,527 US patients undergoing revision hip or knee arthroplasty for periprosthetic joint infection, 2015 to 2023.
  • Compared patients exposed to perioperative dexamethasone with matched unexposed patients in separate nondiabetic (30,644) and diabetic (14,996) cohorts.
  • Dexamethasone was associated with fewer aggregate complications in nondiabetic (aOR 0.934, 95% CI 0.760-0.978) and diabetic patients (aOR 0.814, 95% CI 0.746-0.889).
  • Only diabetic patients had lower mortality (aOR 0.692, 95% CI 0.532-0.901); the authors conclude dexamethasone appears safe regardless of diabetes status.
PubMed indexed 27 Apr 2026 Imported 9 Nov 2026 Jones IA et al. Publisher Perioperative medicinePharmacology
Article Eur J Anaesthesiol Published 15 Apr 2026
Prospective clinical evaluation of the Eleveld pharmacokinetic and pharmacodynamic model of propofol for moderate-to-deep sedation in adults.
AI-generated abstract summary · verify against the original paper
  • Prospective evaluation of 75 adults across three groups (adult, elderly, obese; 25 each) receiving procedural moderate-to-deep sedation.
  • Propofol target-controlled infusion guided by the Eleveld pharmacokinetic-pharmacodynamic model; no comparator group is described.
  • Effect-site targets were generally 2-3 μg/ml in adults and nearer 2 μg/ml in elderly and obese patients, with slight drops in respiratory rate and SpO2 as predicted effect rose.
  • The authors conclude the model can achieve moderate-to-deep sedation while keeping respiratory and haemodynamic parameters adequate, allowing safe completion of procedures.
PubMed indexed 15 Apr 2026 Imported 9 Nov 2026 Driesens MK et al. Publisher Pharmacology
RCT Anaesthesia Published 31 Mar 2026
Lidocaine combined with low-dose esketamine for movement-evoked pain after hepatectomy: a double-blind randomised controlled trial.
AI-generated abstract summary · verify against the original paper
  • Double-blind randomised controlled trial of 304 patients undergoing elective hepatectomy, 48% of whom had open surgery.
  • Patients received lidocaine with low-dose esketamine or placebo from induction to end of surgery, and the active drugs were infused for 72 hours afterward.
  • Movement-evoked pain at 24 hours was lower with lidocaine-esketamine (median 3 vs 4, p < 0.001), with moderate-to-severe pain in 34% vs 56% (p < 0.001).
  • Sufentanil consumption fell and quality of recovery scores were higher over the first 72 hours, but the authors describe these changes as clinically modest.
PubMed indexed 31 Mar 2026 Imported 9 Nov 2026 Xu Y et al. Publisher Pharmacology
Article Anesth Analg Published 18 Feb 2026
Influence of Propofol-Induced Sedation on White Matter Functional Connectivity.
AI-generated abstract summary · verify against the original paper
  • Resting-state fMRI was performed on 21 healthy volunteers across four states: awake, mild sedation, deep propofol sedation, and postsedation recovery.
  • The study compared white matter functional connectivity, both white-to-gray and white-to-white, across these states, with white matter-mediated network global efficiency also analyzed.
  • White-to-gray and white-to-white connectivity significantly decreased during deep sedation versus awake (P < .05), with several tracts differing across states (P < .01).
  • Global efficiency of the whole-brain network and several large-scale networks fell during deep sedation and returned to awake levels after recovery; authors suggest a possible biomarker role.
PubMed indexed 18 Feb 2026 Imported 9 Nov 2026 Zhang J et al. Publisher Pharmacology
Observational Anesth Analg Published 11 Dec 2025
A Comparison of the Analgesia Nociception Index and Nociception Level Index Under General Anesthesia With Propofol and Remifentanil.
AI-generated abstract summary · verify against the original paper
  • Prospective study of 30 adults under general anesthesia with propofol and remifentanil target-controlled infusion, monitored concurrently with ANI and NOL.
  • The two nociception monitors were compared by sorting readings into insufficient, adequate, or excessive analgesia using manufacturer thresholds.
  • Across more than 38 hours of paired recordings, the monitors agreed 43.7% of the time, with 1-category and 2-category disagreements in 37.1% and 8.7% of recordings.
  • Excessive analgesia was recorded for 37.6% (ANI) and 38.1% (NOL) of surgical time, and the authors suggest a multimodal monitoring strategy may help.
PubMed indexed 11 Dec 2025 Imported 9 Nov 2026 Kempe H et al. Publisher Pharmacology
Newer